ATIP - ATI Physical Therapy Corp Market Capitalization-to-Revenue Ratio

Brandmark of ATI Physical Therapy (ATIP)

ATI Physical Therapy (ATIP) efficiency is based on the rehabilitation of transport sector personnel, which enhances overall logistics profitability. The P/S multiple trend on GURU.Markets shows that the current parameter equals 0.00. However, profit depends on insurance payouts and physician availability. Meanwhile, an aging population guarantees stable demand, providing the company with defensive qualities against economic crises.

ATI Physical Therapy Inc. (ATIP) - P/S Multiple from 07/04/2022 to 12/07/2024

Metric breakdowns and analytics for ATI Physical Therapy (ATIP)

- price and consensus price forecast:
General company analysis:ATIP, ATI Physical Therapy Inc.
Mass-produced product of ATI Physical Therapy Inc.

The extensive rehabilitation center network of ATI Physical Therapy (ATIP) relies on localized procurement, which minimizes logistical risks and stabilizes operational flow. By analyzing the price-to-sales ratio, an investor compares market capitalization with sales volume to identify whether the asset is overbought or possesses hidden growth potential through the relationship between the business's valuation and its actual ability to generate revenue.

Competing companies

Price-to-Revenue Coefficient hcahealthcare.com|Tenet Healthcare Corporation - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FMS|SOLV - Price-to-Revenue Ratio|Price-to-Sales Ratio EHC|UHS: P/S Multiple|davita.com - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|Price to Sales Option Care OPCH|Price-to-Revenue Ratio Surgery Partners Corp (SGRY)|Price-to-Revenue Coefficient Premier Health|P/S Multiple EYE (National Vision Holdings)|Price-to-Revenue Coefficient progyny.com (PGNY)|Ardent Health Partners - P/S Multiple|Select Medical Corporation (SEM) - Market Cap to Revenue|ASTH: P/S Multiple|MEDNAX (MD) - P/S Multiple|Price-to-Revenue Ratio US Physical Therapy|Price-to-Revenue Ratio PNTG|Market Cap to Revenue ORGO (Organogenesis)|NUTX (Nutex Health Inc) - Market Capitalization-to-Revenue Ratio|Auna Health - Market Cap to Revenue|Market Cap to Sales Volume SBC (SBC Medical Group Holdings)|Evolus, Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio CYH (chs.net)|SKIN: P/S Multiple|Price to Sales MediWound (MDWD)|Price-to-Revenue Ratio Biote Corp|JYNT: Market Capitalization-to-Revenue Ratio|P/S Multiple DCGO|P/S Multiple p3hp.org (PIII)|Price-to-Revenue Ratio Gain Therapeutics GANX|EUDA (EUDA Health Holdings) - Price-to-Sales Ratio|BMGL: Market Cap to Revenue|Price to Sales CollPlant Biotechnologies|CUPR: P/S Multiple|concordmedical.com (CCM) - P/S Multiple|Market Cap to Revenue AMS|MRM (MEDIROM Healthcare Group Inc.) - Market Cap to Sales Volume|P/S Multiple ALBT|Price-to-Revenue Coefficient DIH Group|Price-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (newgenivf.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Kindly MD Inc - Market Cap to Sales Volume|LogistiCare (MODV) - Price-to-Revenue Ratio|Novo Integrated Sciences Corp - Market Capitalization-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|Price to Sales imacholdings.comm BACK